Overview

Full Product Details

9780128022092

Table of Contents

Reviews

By including studies and recommendations from around the world as well as potential benefits and harms, they have provided a valuable resource for patients, healthcare providers, and public health advocates. Score: 79 - 3 Stars --Doody's, Breast Cancer Screening

By including studies and recommendations from around the world as well as potential benefits and harms, they have provided a valuable resource for patients, healthcare providers, and public health advocates. Score: 79 - 3 Stars --<b>Doody's, <i>Breast Cancer Screening</i></b></p>

Author Information

Dr. Nehmat Houssami is a medical graduate with specialization in Public Health Medicine, and holds an MPH and a PhD (Clinical Epidemiology). She is also a breast physician and clinical researcher who has focused her career on breast cancer, specifically in the screening and diagnosis setting, for the past 22 years. Her expertise includes population screening, breast diagnostic and prognostic testing, cancer staging, and the effect of tests on patients' treatment and clinical outcomes. Dr. Houssami has expertise in systematic evidence reviews and evidence synthesis, and in evaluating new breast screening technologies in the clinical field. Her scholarly work integrates clinical with public health medicine and aims to support evidence-based practice in breast screening and healthcare. She currently leads the breast cancer research portfolio in the Screening & Test Evaluation Program (Sydney Medical School) and the majority of her research is based on leading international collaborations including prospective studies and IPD meta-analyses. Her research portfolio has achieved international recognition. Dr. Houssami is a clinical consultant at the Royal Hospital for Women, Sydney; she is also Co-Editor of The Breast (an Elsevier journal). Diana L. Miglioretti, PhD, is the Dean's Professor of Biostatistics at University of California Davis and a Senior Investigator at Group Health Research Institute. She received her Ph.D. from the Department of Biostatistics at Johns Hopkins University in 2000. Dr. Miglioretti's primary research is in the evaluation of breast cancer screening and breast cancer risk prediction modeling. Dr. Miglioretti has been the principal investigator of the Statistical Coordinating Center for the National Cancer Institute (NCI) funded Breast Cancer Surveillance Consortium (BCSC) since 2005. The BCSC is a collaboration of eight breast imaging registries in the United States. She is currently the contact principal investigator and Biostatistics and Data Management Core Director of the BCSC's multi-site Program Project titled Risk-Based Breast Cancer Screening in Community Settings . She is faculty member for the Radiologic Society of North America's clinical trials methodology workshop.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available